DHRS3 and neoplasm: We show here that RARαS77 hyper-phosphorylation contributes to RA-resistance and tumor progression of TNBC by transcriptional suppression of miR-3074-5p, thus suggesting the RARα/miR-3074-5p/DHRS3 axis may serve as novel therapeutic targets for TNBC.